Clarity Pharmaceuticals (CLRPF, $2.71) was a top loser over the last three months, falling -5 to $2.71 per share. A.I.dvisor analyzed 857 stocks in the Biotechnology Industry for the 3-month period ending December 27, 2024, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend.